Imaging of disease activity in graves' orbitopathy with different methods: comparison of 99mtc-dtpa and 99mtc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores

Nuclear Medicine Communications

Volumn 26, Issue 5, 2005, Pages 407-414

  Galuska, Laszlo ^a   Leovey, Andras ^b   Szucs Farkas, Zsolt ^b   Szabados, Lajos ^b   Garai, Ildiko ^b   Berta, Andras ^b   Balazs, Erzsebet ^b   Varga, Jozsef ^b   Nagy, Endre V ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Medical and Health Sciences Centre   (Hungary)

Author keywords

MRI; Orbitopathy; SPET

Indexed keywords

DEPREOTIDE TC 99M; PENTETATE TECHNETIUM TC 99M;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DRUG ACCUMULATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; HUMAN; INFLAMMATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; FEMALE; GRAVES DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; ORBIT; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SOMATOSTATIN; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 18144370438     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200505000-00003     Document Type: Article

References (16)

1. Heufelder AE. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress. Eur J Endocrinol 1995; 132:532-541.
2. Prummel MF, Wiersinga WM. Medical management of Graves' ophthalmopathy. Thyroid 1995; 5:231-234.
3. Mourits MPH, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, Gaag RVD. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: novel approach. Br J Ophthalmol 1989; 73:639-644.
4. Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am 2000; 29:297-319.
5. Ravin JC, Sisson JC, Knapp WT. Orbital radiation for the ocular changes of Graves' disease. Am J Ophthalmol 1975; 7:285-288.
6. Burggasser G, Hurtl I, Hauff W, Lukas J, Greifeneder M, Heydari B, et al. Orbital scintigraphy with the somatostatin receptor tracer technetium-99m-P829 in patients with Graves' disease. Eur J Nucl Med Suppl 2002; 29(suppl 1):331.
7. Dominguez ML, Llana B, Zeidán N, Suárez JP, Alvarez A, Raigoso P, et al. In 111-octreotide scintigraphy in orbital Graves' disease: a parameter to predict the clinical response to somatostatin analogs therapy? Eur J Nucl Med Suppl 2002; 29(suppl 1):P594.
8. Krassas GE, Kahaly GJ. The role of octreoscan in thyroid eye disease. Eur J Endocrinol 1999; 140:373-375.
9. Krassas GE, Doumas A, Kaltsas TH, Halkias A, Pontikides N. Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease. Thyroid 1999; 1:47-52.
10. Nagy EV, Toth J, Kaldi I, Damjanovich J, Mezosi E, Lenkey A, et al. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol 2000; 142:591-597.
11. 99mTc-DTPA for the assessment of disease activity in Graves's ophthalmopathy: a comparison with the results from MRI. Nucl Med Commun 2002; 23:1211-1216.
12. Galuska L, Varga J, Szucs-Farkas Z, Nagy VE, Burman KD. Differences in SPET analysis of thyroid associated orbitopathy. Eur J Nucl Med 2004; 31:793-795.
13. Carlsen O. The gamma camera as an absolute measurement device: determination of glomerular filtration rate (GFR) in Tc-99m DTPA renography using a dual head gamma camera. Eur J Nucl Med Suppl 2002; 29(suppl 1):443.
14. Burggasser G, Traub T, Hurtl I, Hauff W, Thaler A, Greifeneder M, et al. Comparative orbital scintigraphy with indium-111-DOTA-lanreotide and indium-111-DOTA-Tyr3-octreotide in patients with Graves' disease. Eur J Nucl Med Suppl 2002; 29(suppl 1):332
15. Krassas GE, Doumas A, Pontikides N, Kaltsas TH. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 1999; 42:571-580.
16. Ortapamuk H, Naldoken S, Hosal B. The role of Tc-99m polyclonal human immunoglobulin scintigraphy in Graves' ophthalmopathy. Eur J Nucl Med Suppl 2002; 29(suppl 1):P595.